These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22726372)

  • 1. D-dimer levels in assessing severity and clinical outcome in patients with community-acquired pneumonia. A secondary analysis of a randomised clinical trial.
    Snijders D; Schoorl M; Schoorl M; Bartels PC; van der Werf TS; Boersma WG
    Eur J Intern Med; 2012 Jul; 23(5):436-41. PubMed ID: 22726372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Admission D-dimer can identify low-risk patients with community-acquired pneumonia.
    Chalmers JD; Singanayagam A; Scally C; Hill AT
    Ann Emerg Med; 2009 May; 53(5):633-8. PubMed ID: 19201061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Coagulopathy correlates with outcomes in patients with community- acquired pneumonia].
    Zhuang Q; Zeng Y; Shi Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jun; 37(6):406-10. PubMed ID: 25200038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of D-dimer in predicting mortality in patients with community-acquired pneumonia.
    Nastasijević Borovac D; Radjenović Petković T; Pejčić T; Stanković I; Janković I; Ćirić Z; Rančić M
    Med Glas (Zenica); 2014 Feb; 11(1):37-43. PubMed ID: 24496339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma d-dimer levels increase with the severity of community acquired pneumonia.
    Güneysel O; Pirmit S; Karakurt S
    Tuberk Toraks; 2004; 52(4):341-7. PubMed ID: 15558356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397].
    Christ-Crain M; Morgenthaler NG; Stolz D; Müller C; Bingisser R; Harbarth S; Tamm M; Struck J; Bergmann A; Müller B
    Crit Care; 2006; 10(3):R96. PubMed ID: 16805922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of coagulation parameters on the outcomes of patients with severe community-acquired pneumonia requiring intensive care unit admission.
    Salluh JIF; Rabello LSCF; Rosolem MM; Soares M; Bozza FA; Verdeal JCR; Mello GW; Castro Faria Neto HC; Lapa E Silva JR; Bozza PT
    J Crit Care; 2011 Oct; 26(5):496-501. PubMed ID: 21454038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation and inflammation biomarkers may help predict the severity of community-acquired pneumonia.
    Agapakis DI; Tsantilas D; Psarris P; Massa EV; Kotsaftis P; Tziomalos K; Hatzitolios AI
    Respirology; 2010 Jul; 15(5):796-803. PubMed ID: 20497384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PIRO score for community-acquired pneumonia: a new prediction rule for assessment of severity in intensive care unit patients with community-acquired pneumonia.
    Rello J; Rodriguez A; Lisboa T; Gallego M; Lujan M; Wunderink R
    Crit Care Med; 2009 Feb; 37(2):456-62. PubMed ID: 19114916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-dimer as A Biomarker of Severity and Adverse Outcomes in Patients with Community Acquired Pneumonia.
    Cerda-Mancillas MC; Santiago-Germán D; Andrade-Bravo B; Pedraza-Olivares F; Valenzo-Hernández F; Leaños-Miranda A; Isordia-Salas I
    Arch Med Res; 2020 Jul; 51(5):429-435. PubMed ID: 32402575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of vitamin D status to prognostic scores improves the prediction of outcome in community-acquired pneumonia.
    Remmelts HH; van de Garde EM; Meijvis SC; Peelen EL; Damoiseaux JG; Grutters JC; Biesma DH; Bos WJ; Rijkers GT
    Clin Infect Dis; 2012 Dec; 55(11):1488-94. PubMed ID: 22942205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein is an independent predictor of severity in community-acquired pneumonia.
    Chalmers JD; Singanayagam A; Hill AT
    Am J Med; 2008 Mar; 121(3):219-25. PubMed ID: 18328306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia.
    Hohenthal U; Hurme S; Helenius H; Heiro M; Meurman O; Nikoskelainen J; Kotilainen P
    Clin Microbiol Infect; 2009 Nov; 15(11):1026-32. PubMed ID: 19548923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of haemostasis and endothelial dysfunction characteristics in patient with community-acquired pneumonia].
    Bedilo NV; Vorob'eva NA; Ismaĭlova NV; Veshchagina NA; Nasonov IIa; Malugin IuIu
    Anesteziol Reanimatol; 2014; (1):33-8. PubMed ID: 24749306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free and total cortisol levels as predictors of severity and outcome in community-acquired pneumonia.
    Christ-Crain M; Stolz D; Jutla S; Couppis O; Müller C; Bingisser R; Schuetz P; Tamm M; Edwards R; Müller B; Grossman AB
    Am J Respir Crit Care Med; 2007 Nov; 176(9):913-20. PubMed ID: 17702966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Plasma D-Dimer in Adult Community-Acquired Pneumonia Patients is Associated with an Increased Inflammatory Reaction and Lower Survival.
    Ge YL; Liu CH; Wang N; Xu J; Zhu XY; Su CS; Li HL; Zhang HF; Li ZZ; Li HL; Zhang X; Chen H; Yu HL; Fu AS; Wang HY
    Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and significance of various scores for pneumonia severity in the management of patients with community-acquired pneumonia in China.
    Yang Y; Xu F; Shi LY; Diao R; Cheng YS; Chen XY; Jing JY; Wang XD; Shen HH
    Chin Med J (Engl); 2012 Feb; 125(4):639-45. PubMed ID: 22490488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma d-dimer levels correlate with outcomes in patients with community-acquired pneumonia.
    Querol-Ribelles JM; Tenias JM; Grau E; Querol-Borras JM; Climent JL; Gomez E; Martinez I
    Chest; 2004 Oct; 126(4):1087-92. PubMed ID: 15486368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia.
    Thiem U; Niklaus D; Sehlhoff B; Stückle C; Heppner HJ; Endres HG; Pientka L
    Age Ageing; 2009 Nov; 38(6):693-7. PubMed ID: 19729453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in serum cortisol levels during community-acquired pneumonia: the influence of dexamethasone.
    Remmelts HH; Meijvis SC; Kovaleva A; Biesma DH; Rijkers GT; Heijligenberg R
    Respir Med; 2012 Jun; 106(6):905-8. PubMed ID: 22402329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.